Amneal Pharmaceuticals News

Amneal Pharmaceuticals (AMRX) Receives a Buy From Piper Sandler

TipRanksMay 6 08:28 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaMay 6 08:30 ET

Barclays Sticks to Their Buy Rating for Amneal Pharmaceuticals (AMRX)

TipRanksMay 6 04:45 ET

Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating

MT NewswiresMay 3 14:11 ET

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Amneal Pharmaceuticals (AMRX)

TipRanksMay 2 04:03 ET

Analysts Conflicted on These Healthcare Names: Amneal Pharmaceuticals (AMRX) and Community Health (CYH)

TipRanksApr 25 04:02 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaMar 21 14:05 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaMar 4 09:18 ET

Goldman Sachs Maintains Buy on Amneal Pharmaceuticals, Raises Price Target to $6.25

BenzingaMar 4 09:20 ET

Analysts Offer Insights on Healthcare Companies: Novartis (NVS), Quanterix (QTRX) and Amneal Pharmaceuticals (AMRX)

TipRanksMar 4 07:53 ET

Amneal Pharmaceuticals (AMRX) Gets a Buy From Barclays

TipRanksMar 4 02:55 ET

Strong Growth Ahead: Buy Rating for Amneal Pharmaceuticals Amidst Promising Product Launches and Financial Performance

TipRanksMar 1 17:25 ET

Barclays Remains a Buy on Amneal Pharmaceuticals (AMRX)

TipRanksFeb 22 05:09 ET

Teva Upgraded to Overweight at Piper Sandler on Multiple Expansion

Seeking AlphaFeb 12 09:36 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaJan 29 06:59 ET

Barclays Sticks to Their Buy Rating for Amneal Pharmaceuticals (AMRX)

TipRanksJan 29 05:07 ET

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Veeva Systems (VEEV) and Amneal Pharmaceuticals (AMRX)

TipRanksDec 11, 2023 21:30 ET

Piper Sandler Sticks to Its Buy Rating for Amneal Pharmaceuticals (AMRX)

TipRanksNov 29, 2023 06:37 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Amneal Pharmaceuticals (AMRX) and Hims & Hers Health (HIMS)

TipRanksNov 8, 2023 21:30 ET

Truist Securities Maintains Buy on Amneal Pharmaceuticals, Raises Price Target to $7

BenzingaNov 8, 2023 09:51 ET